跳至主要内容
临床试验/NL-OMON54262
NL-OMON54262招募中不适用

ltra- High field ImaGing in Huntington*s Disease - Ultra-HIGH-D

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • General inclusion criterium:
  • - Between 18 years and 75 years of age
  • Inclusion criteria pre-manifest participants:
  • - An UHDRS motor score <= 5
  • - CAG repeat size of 36 or more
  • Inclusion criteria manifest participants:
  • - An UHDRS motor score > 5
  • - Disease Stage 1 or 2
  • - CAG repeat size of 36 or more
  • - TFC between 7 and 13 (disease stage 1 or 2)
  • Inclusion Criteria gene negative controls
  • - a CAG repeat size of 35 or less

排除标准

  • - Subjects with contra-indications for a MRI-scan as defined in the MRI
  • screening form of SCANNEXUS such as claustrophobia, subjects carrying
  • incompatible metallic devices, subjects who have an allergy for intravenous
  • contract or subjects who are pregnant.
  • - Manifest participants who are not capable of consenting
  • - Manifest patients not capable of undergoing MRI because of involuntary
  • - Genotype unknown
  • - Current participation in a drug trial
  • - Not agreeing to be informed about incidental findings on the MRI scan
  • - Known kidney insufficiency

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验